Response of primary glioblastoma cells to therapy is patient specific and independent of cancer stem cell phenotype.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Neuro-Oncology

• Publication date

  2014-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/neuonc/not223PMID 24311636PMCID PMC3922516
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Temozolomide in combination with carbon ion or photon irradiation in glioblastoma multiforme cell lines – does scheduling matter?

  2013cited by this paper
• Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells.

  2013cited by this paper
• Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics

  2013influential reference
• Evaluation of poly (ADP-ribose) polymerase inhibitor ABT-888 combined with radiotherapy and temozolomide in glioblastoma

  2013cited by this paper
• An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma.

  2013cited by this paper
• The brain microenvironment preferentially enhances the radioresistance of CD133(+) glioblastoma stem-like cells.

  2012cited by this paper
• A restricted cell population propagates glioblastoma growth following chemotherapy

  2012cited by this paper
• A restricted cell population propagates glioblastoma growth after chemotherapy

  2012cited by this paper
• Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response

  2012influential reference
• Valproic acid sensitizes human glioma cells for temozolomide and γ-radiation

  2012cited by this paper
• Determination of the methylation status of MGMT in different regions within glioblastoma multiforme

  2011influential reference
• Chemoresistance of glioblastoma cancer stem cells - much more complex than expected

  2011cited by this paper
• Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide

  2010cited by this paper
• Clinical outcome in pediatric glial and embryonal brain tumors correlates with in vitro multi‐passageable neurosphere formation

  2010cited by this paper
• O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients.

  2010cited by this paper
• Microenvironmental Regulation of Glioblastoma Radioresponse

  2010cited by this paper
• Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

  2009influential reference
• CD133+ Glioblastoma Stem-like Cells are Radiosensitive with a Defective DNA Damage Response Compared with Established Cell Lines

  2009influential reference
• Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens.

  2009influential reference
• Neurosphere Formation Is an Independent Predictor of Clinical Outcome in Malignant Glioma

  2009cited by this paper
• SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma.

  2009cited by this paper
• Molecular Cancer BioMed Central

  2008influential reference
• Temozolomide preferentially depletes cancer stem cells in glioblastoma.

  2008cited by this paper
• Downregulation of RUNX3 and TES by hypermethylation in glioblastoma

  2007cited by this paper
• Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine

  2007cited by this paper
• Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

  2006cited by this paper
• O6‐methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells

  2006cited by this paper
• Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.

  2006cited by this paper
• Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

  2006cited by this paper
• MGMT gene silencing and benefit from temozolomide in glioblastoma.

  2005influential reference
• Identification of human brain tumour initiating cells

  2004cited by this paper
• MGMT: its role in cancer aetiology and cancer therapeutics

  2004cited by this paper
• Dual repair modulation reverses Temozolomide resistance in vitro.

  2004cited by this paper
• Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Temozolomide in Malignant Glioma Patients

  2004cited by this paper
• The Effect of O 6-Alkylguanine-DNA Alkyltransferase and Mismatch Repair Activities on the Sensitivity of Human Melanoma Cells to Temozolomide, 1,3-bis(2-Chloroethyl)1-nitrosourea, and Cisplatin

  2003cited by this paper
• Identification of a cancer stem cell in human brain tumors.

  2003cited by this paper
• Clinical relevance of MGMT in the treatment of cancer.

  2002cited by this paper
• p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells.

  2001influential reference
• Temozolomide and treatment of malignant glioma.

  2000influential reference
• Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia.

  1999cited by this paper
• Graded methylation in the promoter and body of the O6-methylguanine DNA methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cells.

  1994cited by this paper
• Identification of a 59 bp enhancer located at the first exon/intron boundary of the human O6-methylguanine DNA methyltransferase gene.

  1994cited by this paper
• Methylation-related chromatin structure is associated with exclusion of transcription factors from and suppressed expression of the O-6-methylguanine DNA methyltransferase gene in human glioma cell lines

  1994cited by this paper
• Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents.

  1990influential reference
• Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents.

  1990cited by this paper
• Age-related chemosensitivity of stem cells from human malignant brain tumours.

  1982cited by this paper
• Brain-tumor therapy. Quantitative analysis using a model system.

  1977cited by this paper
• In vitro evaluation of in vivo brain tumor chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea.

  1975cited by this paper

• VAL-083 is effective in patients with newly-diagnosed MGMT-unmethylated glioblastoma: report of phase II study

  2025cites this paper
• Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers

  2023cites this paper
• Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells

  2023cites this paper
• GABP couples oncogene signaling to telomere regulation in TERT promoter mutant cancer

  2022cites this paper
• Dynamically Crosslinked Poly(ethylene‐glycol) Hydrogels Reveal a Critical Role of Viscoelasticity in Modulating Glioblastoma Fates and Drug Responses in 3D

  2022cites this paper
• Understanding the Biological Basis of Glioblastoma Patient-derived Spheroids

  2021cites this paper
• Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma

  2021cites this paper
• Phosphoglycerate Mutase 1 Activates DNA Damage Repair via Regulation of WIP1 Activity.

  2020cites this paper
• EZH2 Phosphorylation Promotes Self-Renewal of Glioma Stem-Like Cells Through NF-κB Methylation

  2019cites this paper
• Cancer stem cell (CSC) resistance drivers.

  2019cites this paper
• Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment

  2019cites this paper
• The clinicopathological significance of CD133 and Sox2 in astrocytic glioma

  2018cites this paper
• Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner.

  2018cites this paper
• A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells

  2018cites this paper
• Inhibition of glioblastoma cell proliferation, invasion, and mechanism of action of a novel hydroxamic acid hybrid molecule

  2018cites this paper
• Radioresistance of mesenchymal glioblastoma initiating cells correlates with patient outcome and is associated with activation of inflammatory program

  2017cites this paper
• The Impact of the Tumor Microenvironment on the Properties of Glioma Stem-Like Cells

  2017cites this paper
• Molecular Genetics of Secondary Glioblastoma

  2017cites this paper
• Malignant Glioma In Vitro Models: On the Utilization of Stem-like Cells.

  2017cites this paper
• Brain Tumor Stem Cells Remain in Play.

  2017cites this paper
• A radiosensitizing effect of RAD51 inhibition in glioblastoma stem-like cells

  2016cites this paper
• Analysis of the safety of mesenchymal stromal cells secretome for glioblastoma treatment.

  2016cites this paper
• Issues to Consider in Designing Immunotherapy Clinical Trials for Glioblastoma Management

  2016cites this paper
• Large-scale Computational Screening and Machine Learning Approaches to Drug Discovery

  2016influential citation
• Temozolomide promotes genomic and phenotypic changes in glioblastoma cells

  2016cites this paper
• Alteration of DNA damage signaling pathway profile in radiation-treated glioblastoma stem-like cells.

  2015cites this paper
• Combination therapies in a patient-derived glioblastoma model

  2015cites this paper
• Epigenetic Pathways and Glioblastoma Treatment: Insights From Signaling Cascades

  2015cites this paper
• Targeting a Plk1-Controlled Polarity Checkpoint in Therapy-Resistant Glioblastoma-Propagating Cells.

  2015cites this paper
• Coexpression analysis of CD133 and CD44 identifies Proneural and Mesenchymal subtypes of glioblastoma multiforme

  2015cites this paper
• Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs

  2015cites this paper
• Anatomical specificity of O6-methylguanine DNA methyltransferase protein expression in glioblastomas

  2014cites this paper
• Metformin plus sorafenib highly impacts temozolomide resistant glioblastoma stem-like cells.

  2014cites this paper
• Glioblastoma stem-like cells: approaches for isolation and characterization

  2014cites this paper